The Clinical and Administrative Core provides essential operational functions for the entire PPG. This Core will recruit patients with frontotemporal dementia (FTD), semantic dementia (SD), progressive non-fluent aphasia (PNFA), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and normal control subjects. Each subject will receive a comprehensive evaluation measuring a broad range of neurological, neuropsychological, functional, neurobehavioral, and social-personality variables. In addition, subjects will be followed annually to collect longitudinal data and maintain high enrollment in our autopsy program. Administrative functions of this Core include the infrastructure for establishing policies and procedures, maintaining communication within the PPG and between the PPG and the scientific community, ensuring optimal utilization and monitoring of PPG resources, and ensuring the scientific and ethical integrity of all PPG practices. Once recruited into the Clinical and Administrative Core, subjects will be referred to Core E (Dr. Rosen) for imaging and Projects 2 (Imaging;Dr. Weiner), 3 (Emotion;Dr. Levenson), 4 (Clinical Diagnosis;Dr. Miller), and 6 (Network Biomarkers;Dr. Seeley). In addition, blood samples will be sent to the Genetics Core (Dr. Geschwind) and autopsy tissue will be sent to the Pathology Core (Drs. Seeley &Trojanowski).

Public Health Relevance

Core A will benefit the public health by advancing the understanding of frontotemporal dementia and identify the best diagnostic tools and potentially uncover treatment targets. If successful, this work could accelerate the search for new therapies for prevalent age-related neurodegnerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG019724-12
Application #
8531782
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
12
Fiscal Year
2013
Total Cost
$426,552
Indirect Cost
$56,554
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Taylor, Alexander N W; Kambeitz-Ilankovic, Lana; Gesierich, Benno et al. (2017) Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease. Alzheimers Dement 13:225-235
Riancho, Javier; Pozueta, Ana; Santos, Miguel et al. (2017) Logopenic Aphasia due to a Strategic Stroke: New Evidence from a Single Case. J Alzheimers Dis 57:717-721
Olney, Nicholas T; Spina, Salvatore; Miller, Bruce L (2017) Frontotemporal Dementia. Neurol Clin 35:339-374
Hagedorn, Christina; Proctor, Michael; Goldstein, Louis et al. (2017) Characterizing Articulation in Apraxic Speech Using Real-Time Magnetic Resonance Imaging. J Speech Lang Hear Res 60:877-891
Gola, Kelly A; Shany-Ur, Tal; Pressman, Peter et al. (2017) A neural network underlying intentional emotional facial expression in neurodegenerative disease. Neuroimage Clin 14:672-678
Watson, Christa L; Possin, Katherine; Allen, I Elaine et al. (2017) Visuospatial Functioning in the Primary Progressive Aphasias. J Int Neuropsychol Soc :1-10
Lwi, Sandy J; Ford, Brett Q; Casey, James J et al. (2017) Poor caregiver mental health predicts mortality of patients with neurodegenerative disease. Proc Natl Acad Sci U S A 114:7319-7324
Spina, Salvatore; Schonhaut, Daniel R; Boeve, Bradley F et al. (2017) Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology 88:758-766
Elahi, Fanny M; Miller, Bruce L (2017) A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13:457-476
Spinelli, Edoardo G; Mandelli, Maria Luisa; Miller, Zachary A et al. (2017) Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol 81:430-443

Showing the most recent 10 out of 563 publications